Literature DB >> 12807311

Snake antivenoms.

David G Lalloo1, R David G Theakston.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12807311     DOI： 10.1081/clt-120021113

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN： 0731-3810


× No keyword cloud information.
  34 in total

1.  Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Authors:  Juan J Calvete; Pedro Cid; Libia Sanz; Alvaro Segura; Mauren Villalta; María Herrera; Guillermo León; Robert Harrison; Nandul Durfa; Abdusalami Nasidi; R David G Theakston; David A Warrell; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 2.  Adverse reactions to snake antivenom, and their prevention and treatment.

Authors:  H Asita de Silva; Nicole M Ryan; H Janaka de Silva
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

3.  Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy.

Authors:  Sedigheh Khamehchian; Hossein Zolfagharian; Naser Mohammadpour Dounighi; Majid Tebianian; Rasool Madani
Journal:  Hum Vaccin Immunother       Date:  2014-03-18       Impact factor: 3.452

4.  Propensity of crocin to offset Vipera russelli venom induced oxidative stress mediated neutrophil apoptosis: a biochemical insight.

Authors:  M Sebastin Santhosh; M Shanmuga Sundaram; K Sunitha; S Jnaneshwari; S Devaraja; K Kemparaju; K S Girish
Journal:  Cytotechnology       Date:  2014-08-23       Impact factor: 2.058

5.  A controlled clinical trial of a novel antivenom in patients envenomed by Bungarus multicinctus.

Authors:  Tran Hung Ha; Jonas Höjer; Xuan Kiem Trinh; Thi Du Nguyen
Journal:  J Med Toxicol       Date:  2010-12

6.  The structure of MP-4 from Mucuna pruriens at 2.22 Å resolution.

Authors:  Abha Jain; Amit Kumar; Meha Shikhi; Ashish Kumar; Deepak T Nair; Dinakar M Salunke
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-02-03       Impact factor: 1.056

Review 7.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Recombinant expression and purification of human placental growth factor 1 and specific camel heavy chain polyclonal antibody preparation.

Authors:  Roghaye Arezumand; Reza Mahdian; Mahdi Behdani; Hossein Khanahmad; Jahangir Langari; Nabiollah Namvarasl; Reza Hassanzadeh-Ghasabeh; Sirous Zeinali
Journal:  Saudi J Biol Sci       Date:  2013-05-07       Impact factor: 4.219

9.  Antisnake Venom Activity of Hibiscus aethiopicus L. against Echis ocellatus and Naja n. nigricollis.

Authors:  S S Hasson; A A Al-Jabri; T A Sallam; M S Al-Balushi; R A A Mothana
Journal:  J Toxicol       Date:  2010-06-06

10.  Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.

Authors:  H Asita de Silva; Arunasalam Pathmeswaran; Channa D Ranasinha; Shaluka Jayamanne; Senarath B Samarakoon; Ariyasena Hittharage; Ranjith Kalupahana; G Asoka Ratnatilaka; Wimalasiri Uluwatthage; Jeffrey K Aronson; Jane M Armitage; David G Lalloo; H Janaka de Silva
Journal:  PLoS Med       Date:  2011-05-10       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.